[PRESS RELEASE] – MINNEAPOLIS, Nov. 2, 2026 – Vireo Growth Inc., a leading cannabis company and agricultural markets platform, announced that it has received registrations from the U.S. Drug Enforcement Administration (DEA) for all 41 of its state-licensed medical cannabis dispensaries in Florida.
Vireo's registrations are among the initial federal registrations issued by the DEA to qualifying state-licensed medical marijuana dispensaries under the new Schedule III framework established by the DEA’s April 2026 final rule. The initial issuance represents an important regulatory milestone for Vireo's Florida operations and the broader medical cannabis industry.
“Florida is one of our key markets, and we are pleased to have received these registrations,” Vireo CEO John Mazarakis said. “We appreciate the DEA’s efforts in advancing this process and welcome continued progress toward a federal regulatory framework that recognizes responsible, state-licensed cannabis operators and supports a more stable and sustainable industry.”
